Journal of General Internal Medicine

, Volume 22, Issue 8, pp 1190–1194

Update in Addiction Medicine for the Generalist

  • Adam J. Gordon
  • Lynn E. Sullivan
  • Daniel P. Alford
  • Julia H. Arnsten
  • Marc N. Gourevitch
  • Stefan G. Kertesz
  • Hillary V. Kunins
  • Joseph O. Merrill
  • Jeffrey H. Samet
  • David A. Fiellin
Updates

KEY WORDS

primary health care substance-related disorders review literature 

References

  1. 1.
    Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.PubMedCrossRefGoogle Scholar
  2. 2.
    Substance Abuse and Mental Health Services Administration Office of Applied Studies. Results from the 2004 Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration Office of Applied Studies; 2005. DHHS publication no. SMA 05-4062, NSDUH series H-28.Google Scholar
  3. 3.
    Grant BF, Dawson DA, Stinson FS, et al. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend. 2004;74(3):223–34.PubMedCrossRefGoogle Scholar
  4. 4.
    Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596–607.PubMedCrossRefGoogle Scholar
  5. 5.
    Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(7):557–68.PubMedGoogle Scholar
  6. 6.
    Pettinati HM, Weiss RD, Miller WR, Donovan D, Denise B, Rounsaville BJ. COMBINE Monograph Series, Volume 2. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004. DHHS publication no. (NIH) 04-5289.Google Scholar
  7. 7.
    Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA. 2006;295(17):2003–17.PubMedCrossRefGoogle Scholar
  8. 8.
    Pettinati HM, Weiss RD, Dundon W, et al. A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl. 2005;(15):170–8.Google Scholar
  9. 9.
    Miller WR. Combined behavioral intervention manual. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004. NIH publication no. 04-5288.Google Scholar
  10. 10.
    Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617–25.PubMedCrossRefGoogle Scholar
  11. 11.
    Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol. 2001;62(2):211–20.PubMedGoogle Scholar
  12. 12.
    Tucker JA, Roth DL. Extending the evidence hierarchy to enhance evidence-based practice for substance use disorders. Addiction. 2006;101(7):918–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Agency for Healthcare Research and Quality. The Guide to Clinical Preventive Services, 2005. Recommendations of the U.S. Preventive Services Task Force. Available at http://www.preventiveservices.ahrq.gov. Accessed December 1, 2006.
  14. 14.
    McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45.PubMedCrossRefGoogle Scholar
  15. 15.
    National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much: A Clinician’s Guide. Rockville, MD: U.S. Department of Health & Human Services; 2005. NIH publication no. 05-3769.Google Scholar
  16. 16.
    Fleming MF. In search of the Holy Grail for the detection of hazardous drinking. J Fam Pract. 2001;50(4):321–2.PubMedGoogle Scholar
  17. 17.
    Gordon AJ, Maisto SA, McNeil M, et al. Three questions can detect hazardous drinkers. J Fam Pract. 2001;50(4):313–20.PubMedGoogle Scholar
  18. 18.
    Canagasaby A, Vinson DC. Screening for hazardous or harmful drinking using one or two quantity–frequency questions. Alcohol Alcohol. 2005;40(3):208–13.PubMedGoogle Scholar
  19. 19.
    Williams R, Vinson DC. Validation of a single screening question for problem drinking. J Fam Pract. 2001;50(4):307–12.PubMedGoogle Scholar
  20. 20.
    Vinson DC. Screening question for alcohol abuse. Am Fam Physician. 2002;66(2):209.PubMedGoogle Scholar
  21. 21.
    Taj N, Devera-Sales A, Vinson DC. Screening for problem drinking: does a single question work? J Fam Pract. 1998;46(4):328–35.PubMedGoogle Scholar
  22. 22.
    National Center For Chronic Disease Prevention and Health Promotion, Center for Disease Control. Percentage of adults who were current, former, or never smokers, overall and by sex, race, Hispanic origin, age, and education, National Health Interview Surveys, selected years—United States, 1965–2000. Available at: http://www.cdc.gov/tobacco/research_data/adults_prev/adstat1print.htm. Accessed October 5, 2006.
  23. 23.
    Centers for Disease Control and Prevention. Smoking-attributable mortality and years of potential life lost—United States, 1984. MMWR Morb Mortal Wkly Rep. 1997;46(20):444–51.Google Scholar
  24. 24.
    Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2004;(1):CD003041.Google Scholar
  25. 25.
    Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology. 1993;4(4):295–302.PubMedCrossRefGoogle Scholar
  26. 26.
    Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84.PubMedCrossRefGoogle Scholar
  27. 27.
    Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.CrossRefGoogle Scholar
  28. 28.
    National Cholesterol Education Program Expert Panel on Detection EaToHBCiAATPI. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.Google Scholar
  29. 29.
    Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827–38.PubMedCrossRefGoogle Scholar
  30. 30.
    Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227–39.PubMedCrossRefGoogle Scholar
  31. 31.
    The Tobacco Use and Dependence Clinical Practice Guideline Panel SaCR. A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. JAMA. 2000;283(24):3244–54.CrossRefGoogle Scholar
  32. 32.
    Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA. 1998;279(8):604–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55.PubMedCrossRefGoogle Scholar
  34. 34.
    Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56–63.PubMedCrossRefGoogle Scholar
  35. 35.
    Tonstad S, Tonnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):64–71.PubMedCrossRefGoogle Scholar
  36. 36.
    Johnston LD, O’Malley PM, Backman JG, Schulenberg JE. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings. Bethesda, MD: National Institute on Drug Abuse; 2005.Google Scholar
  37. 37.
    Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35(12):1747–59.PubMedCrossRefGoogle Scholar
  38. 38.
    Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage. 2004;28(2):176–88.PubMedCrossRefGoogle Scholar
  39. 39.
    Turner BJ, Laine C, Lin YT, Lynch K. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Arch Intern Med. 2005;165(15):1769–76.PubMedCrossRefGoogle Scholar
  40. 40.
    Institute of Medicine. Improving the Quality of Healthcare for Mental and Substance-use Conditions: The Quality Chasm Series. Washington, DC: The National Academies Press; 2005.Google Scholar
  41. 41.
    Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: The National Academies Press; 2001.Google Scholar

Copyright information

© Society of General Internal Medicine 2007

Authors and Affiliations

  • Adam J. Gordon
    • 1
    • 2
    • 3
  • Lynn E. Sullivan
    • 4
  • Daniel P. Alford
    • 5
  • Julia H. Arnsten
    • 6
  • Marc N. Gourevitch
    • 7
  • Stefan G. Kertesz
    • 8
  • Hillary V. Kunins
    • 6
  • Joseph O. Merrill
    • 9
  • Jeffrey H. Samet
    • 5
  • David A. Fiellin
    • 4
  1. 1.Mental Illness Research, Education, and Clinical, CenterUniversity of PittsburghPittsburghUSA
  2. 2.Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare SystemPittsburghUSA
  3. 3.Center for Research on Health CareUniversity of PittsburghPittsburghUSA
  4. 4.Yale University School of MedicineNew HavenUSA
  5. 5.Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of MedicineBoston University School of MedicineBostonUSA
  6. 6.Albert Einstein College of Medicine and Montefiore Medical CenterNew YorkUSA
  7. 7.New York University School of MedicineNew YorkUSA
  8. 8.University of Alabama at Birmingham School of Medicine, and the Deep South Center on EffectivenessBirmingham Veterans Affairs Medical CenterBirminghamUSA
  9. 9.University of Washington School of MedicineSeattleUSA

Personalised recommendations